Racial Differences in the Prevalence of Atrial Fibrillation among Males

作者: Ann M. Borzecki , D. Keith Bridgers , Jane M. Liebschutz , Boris Kader , ScD Lewis E. Kazis

DOI: 10.1016/S0027-9684(15)31212-8

关键词:

摘要: Background Despite being the most common cardiac arrhythmia, little is known about racial differences in atrial fibrillation (AF) prevalence and whether persist after accounting for risk factors. Methods We identified male respondents to 1999 Large Health Survey of Veteran Enrollees who had an AF diagnosis VA administrative database during preceding two years. Results Of 664,754 respondents, 5.3% AF. By race, age-adjusted was 5.7% whites, 3.4% blacks, 3.0% Hispanics, 5.4% native Americans/Alaskans, 3.6% Asians 5.2% Pacific Islanders (p  Conclusions varies by race. White males have highest burden even adjustment Recognition high prevalence, especially among as well Americans Islanders, should help guide provider practices screening older patients. Further research necessary verify establish reasons these differences.

参考文章(31)
Jeff Whittle, Chester B Good, Barbara H Hanusa, Hyasmine Charles, Chung-Chou H Chang, Racial differences in adherence to cardiac medications. Journal of The National Medical Association. ,vol. 95, pp. 17- 27 ,(2003)
Andrea Rossi, Maurice Enriquez-Sarano, John C Burnett, Amir Lerman, Martin D Abel, James B Seward, Natriuretic peptide levels in atrial fibrillation: A prospective hormonal and Doppler-echocardiographic study Journal of the American College of Cardiology. ,vol. 35, pp. 1256- 1262 ,(2000) , 10.1016/S0735-1097(00)00515-5
Bernice Ruo, Angela M Capra, Nancy G Jensvold, Alan S Go, Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study Journal of the American College of Cardiology. ,vol. 43, pp. 429- 435 ,(2004) , 10.1016/J.JACC.2003.09.035
David Bush, Lisa W Martin, Robert Leman, Mary Chandler, L Julian Haywood, NHLBI AFFIRM Investigators, None, Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial. Journal of The National Medical Association. ,vol. 98, pp. 330- 339 ,(2006)
Philip A. Wolf, Emelia J. Benhamin, Albert J. Belanger, William B. Kannel, Daniel Levy, Ralph B. D'Agostino, Secular trends in the prevalence of atrial fibrillation: The Framingham study American Heart Journal. ,vol. 131, pp. 790- 795 ,(1996) , 10.1016/S0002-8703(96)90288-4
Simon Stewart, Carole L Hart, David J Hole, John J.V McMurray, A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study The American Journal of Medicine. ,vol. 113, pp. 359- 364 ,(2002) , 10.1016/S0002-9343(02)01236-6
Branko Kopjar, Anne E.B. Sales, Sandra L. Piñeros, Haili Sun, Yu-Fang Li, Ashley N. Hedeen, Adherence with statin therapy in secondary prevention of coronary heart disease in veterans administration male population American Journal of Cardiology. ,vol. 92, pp. 1106- 1108 ,(2003) , 10.1016/J.AMJCARD.2003.07.008
Emelia J Benjamin, Daniel Levy, Sonya M Vaziri, Ralph B D'Agostino, Albert J Belanger, Philip A Wolf, Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. ,vol. 271, pp. 840- 844 ,(1994) , 10.1001/JAMA.1994.03510350050036
Thomas J. Wang, Martin G. Larson, Daniel Levy, Emelia J. Benjamin, Eric P. Leip, Torbjorn Omland, Philip A. Wolf, Ramachandran S. Vasan, Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death New England Journal of Medicine. ,vol. 350, pp. 655- 663 ,(2004) , 10.1056/NEJMOA031994